# Corticoids in Severe Community-Acquired Pneumonia (CAP)

> **NCT00908713** · PHASE4 · COMPLETED · sponsor: **Hospital Clinic of Barcelona** · enrollment: 120 (actual)

## Conditions studied

- Community-Acquired Pneumonia

## Interventions

- **DRUG:** methylprednisolone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00908713
- **Lead sponsor:** Hospital Clinic of Barcelona
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2012-02
- **Final completion:** 2012-03
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2013-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00908713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00908713, "Corticoids in Severe Community-Acquired Pneumonia (CAP)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00908713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*